Brachytherapy for prostate cancer in Uni-asia Cancer hospital

Brachytherapy for prostate cancer at Uni-Asia Cancer Hospital in Chengdu, China, provides a focused alternative to traditional surgery. This minimally invasive treatment uses iodine-125 seed implantation to target tumors from the inside. The hospital specializes in oncology and uses advanced image guidance to help patients with low- to intermediate-risk prostate cancer.

The Brachytherapy Procedure

The procedure involves placing miniature radioactive seeds directly into the prostate gland. Doctors use titanium-alloy seeds about the size of a grain of rice. These seeds deliver continuous, low-dose radiation for several months. This method helps destroy cancer cells while protecting the bladder and rectum. The iodine-125 seeds have a half-life of about 55 days, slowly losing their radioactivity over time. Because the radiation travels only a short distance, it stays inside the target area.

Advanced Planning and Precision

Success depends on exact placement. Before the procedure, the medical team uses a three-dimensional treatment planning system (TPS). This software creates a map for the seeds to achieve the best dose distribution. During the actual implantation, specialists use real-time CT or ultrasound guidance. This imaging allows for percutaneous implantation, meaning the seeds are placed through the skin without large incisions. This precise targeting helps keep healthy surrounding tissues safe from radiation.

Benefits of Seed Implantation

This approach offers several advantages for patients seeking less invasive options. It removes the need for open surgery and reduces the recovery time. Key features of the treatment include:

• Individualized planning using 3D TPS software for every patient.
• Real-time guidance with CT or ultrasound to help the doctor place seeds accurately.
• Minimal side effects due to the titanium-alloy shells that shield nearby organs.
• Continuous therapy that works for months without daily hospital visits.

Specialized Care in Chengdu

Uni-Asia Cancer Hospital focuses on minimally invasive oncology across its Chengdu and Zigong campuses. The facility uses a multidisciplinary team to manage each case. This team includes specialists who coordinate the planning, implantation, and follow-up care. Patients receive a treatment plan designed for their specific tumor size and location. You can request a consultation or learn more about this procedure by leaving a request on Bookimed.